Catalyst Wire Dossier Catalyst Wire Dossier

Spanidin

gusperimus · Euro Nippon Kayaku GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Spanidin, covering 2008-06-19 to 2008-06-19. Get the full timeline:

Most recent: Euro Nippon Kayaku GmbH withdraws its marketing authorisation application for Spanidin (gusperimus)

See pricing